Mass entrainment and turbulence-driven acceleration of ultra-high energy cosmic rays in Centaurus A

Observations of the FR I radio galaxy Centaurus A in radio, X-ray, and gamma-ray bands provide evidence for lepton acceleration up to several TeV and clues about hadron acceleration to tens of EeV. Synthesising the available observational constraints on the physical conditions and particle content in the jets, inner lobes and giant lobes of Centaurus A, we aim to evaluate its feasibility as an ultra-high-energy cosmic-ray source. We apply several methods of determining jet power and affirm the consistency of various power estimates of ~1 × 10⁴³ erg s⁻¹. Employing scaling relations based on previous results for 3C 31, we estimate particle number densities in the jets, encompassing available radio through X-ray observations. Our model is compatible with the jets ingesting ~3 × 10²¹ g s⁻¹ of matter via external entrainment from hot gas and ~7 × 10²² g s⁻¹ via internal entrainment from jet-contained stars. This leads to an imbalance between the internal lobe pressure available from radiating particles and magnetic field, and our derived external pressure. Based on knowledge of the external environments of other FR I sources, we estimate the thermal pressure in the giant lobes as 1.5 × 10⁻¹² dyn cm⁻², from which we deduce a lower limit to the temperature of ~1.6 × 10⁸ K. Using dynamical and buoyancy arguments, we infer ~440−645 Myr and ~560 Myr as the sound-crossing and buoyancy ages of the giant lobes respectively, inconsistent with their spectral ages. We re-investigate the feasibility of particle acceleration via stochastic processes in the lobes, placing new constraints on the energetics and on turbulent input to the lobes. The same “very hot” temperatures that allow self-consistency between the entrainment calculations and the missing pressure also allow stochastic UHECR acceleration models to work.Sarka Wykes, Judith H. Croston, Martin J. Hardcastle, Jean A. Eilek, Peter L. Biermann, Abraham Achterberg, Justin D. Bray, Alex Lazarian, Marijke Haverkorn, Ray J. Protheroe, and Omer Bromber

A lab-on-chip for malaria diagnosis and surveillance

This study examines a lab-on-chip that was created to overcome barriers in technology, reagent storage, cost and expertise in this study a simple, lab-on-chip PCR diagnostic was created for malaria testing.Background: Access to timely and accurate diagnostic tests has a significant impact in the management of diseases of global concern such as malaria. While molecular diagnostics satisfy this need effectively in developed countries, barriers in technology, reagent storage, cost and expertise have hampered the introduction of these methods in developing countries. In this study a simple, lab-on-chip PCR diagnostic was created for malaria that overcomes these challenges. Methods: The platform consists of a disposable plastic chip and a low-cost, portable, real-time PCR machine. The chip contains a desiccated hydrogel with reagents needed for Plasmodium specific PCR. Chips can be stored at room temperature and used on demand by rehydrating the gel with unprocessed blood, avoiding the need for sample preparation. These chips were run on a custom-built instrument containing a Peltier element for thermal cycling and a laser/camera setup for amplicon detection. Results: This diagnostic was capable of detecting all Plasmodium species with a limit of detection for Plasmodium falciparum of 2 parasites/μL of blood. This exceeds the sensitivity of microscopy, the current standard for diagnosis in the field, by ten to fifty-fold. In a blind panel of 188 patient samples from a hyper-endemic region of malaria transmission in Uganda, the diagnostic had high sensitivity (97.4%) and specificity (93.8%) versus conventional real-time PCR. The test also distinguished the two most prevalent malaria species in mixed infections, P. falciparum and Plasmodium vivax. A second blind panel of 38 patient samples was tested on a streamlined instrument with LED-based excitation, achieving a sensitivity of 96.7% and a specificity of 100%. Conclusions: These results describe the development of a lab-on-chip PCR diagnostic from initial concept to ready-for-manufacture design. This platform will be useful in front-line malaria diagnosis, elimination programmes, and clinical trials. Furthermore, test chips can be adapted to detect other pathogens for a differential diagnosis in the field. The flexibility, reliability, and robustness of this technology hold much promise for its use as a novel molecular diagnostic platform in developing countries

Microfluidic Platform for Single Nucleotide Polymorphism Genotyping of the Thiopurine S-Methyltransferase Gene to Evaluate Risk for Adverse Drug Events

Prospective clinical pharmacogenetic testing of the thiopurine S-methyltransferase gene remains to be realized despite the large body of evidence demonstrating clinical benefit for the patient and cost effectiveness for health care systems. We describe an entirely microchip-based method to genotype for common single nucleotide polymorphisms in the thiopurine S-methyltransferase gene that lead to serious adverse drug reactions for patients undergoing thiopurine therapy. Restriction fragment length polymorphism and allele-specific polymerase chain reaction have been adapted to a microfluidic chip-based polymerase chain reaction and capillary electrophoresis platform to genotype the common *2, *3A, and *3C functional alleles. In total, 80 patients being treated with thiopurines were genotyped, with 100% concordance between microchip and conventional methods. This is the first report of single nucleotide polymorphism detection using portable instrumentation and represents a significant step toward miniaturized for personalized treatment and automated point-of-care testing